FacebookXInstagramTelegram
WhatsApp! 020-122-280-6824

About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
19 12, 2025

USD/JPY Forecast 19/12: Pullbacks Attract Buyers (Chart)

By |2025-12-19T04:18:56+02:00December 19, 2025|Forex News, News|0 Comments

  • The US dollar reversed after an initial rally as softer CPI data fueled rate-cut speculation, keeping USD/JPY volatile.
  • Despite near-term noise and Bank of Japan risk, pullbacks are viewed as buying opportunities amid a persistent rate differential.

The US dollar initially rallied during the trading session on Thursday, but gave back gains rather quickly, mainly due to the CPI numbers coming out with a lower-than-anticipated number in the United States. Therefore, people are starting to focus on the idea of whether or not the Federal Reserve may have to cut rates more quickly.

With that being the case, the market remains very noisy, and it does make a certain amount of sense that we continue to see a lot of volatility, but that’s nothing new for this pair. Furthermore, you also have to keep in mind that on Friday, we get the interest rate decision coming out of the Bank of Japan, so this is a pair that could get turned around right away.

Key Levels, Policy Risk, and Trade Bias

With that being the case, this is watched very closely, and pullbacks are being viewed at this point in time as buying opportunities. The 50-day EMA is near the 4.12 level and rising, and it should offer a little bit of support. The ¥158 level above is where a potential target is being watched.

Whether or not the market gets there between now and the end of the year is a completely different question, but it is expected eventually. The interest rate differential will continue to favor the Americans for the foreseeable future, and inflation and growth in the United States are expected to remain above the optimal level for the central bank. Therefore, the Federal Reserve will likely have to be a little cautious with its rate-cutting cycle.

This does not appear to be a major inflection point, at least not yet. As a result, there is no real reason to believe that the Japanese yen is going to appreciate significantly. There may be the potential for a pullback in this pair after the Bank of Japan statement or press conference, but that should be looked at as a potential opportunity.

Want to trade our USD/JPY forex analysis and predictions? Here’s a list of forex brokers in Japan to check out.

Christopher Lewis has been trading Forex and has over 20 years experience in financial markets. Chris has been a regular contributor to Daily Forex since the early days of the site. He writes about Forex for several online publications, including FX Empire, Investing.com, and his own site, aptly named The Trader Guy. Chris favours technical analysis methods to identify his trades and likes to trade equity indices and commodities as well as Forex. He favours a longer-term trading style, and his trades often last for days or weeks.

Source link

Read More
19 12, 2025

MATIC Price Prediction: $0.45 Target by January 2026 Despite Current Technical Weakness

By |2025-12-19T04:03:35+02:00December 19, 2025|Crypto News, News|0 Comments



Ted Hisokawa
Dec 18, 2025 08:21

MATIC price prediction suggests a recovery to $0.45 within 4-6 weeks, though immediate bearish momentum could test $0.33 support first.

MATIC Price Prediction: Technical Recovery Expected Despite Near-Term Headwinds

MATIC Price Prediction Summary

• MATIC short-term target (1 week): $0.35-$0.40 (-8% to +5% from current $0.38)
• Polygon medium-term forecast (1 month): $0.42-$0.47 range (+11% to +24% upside)
• Key level to break for bullish continuation: $0.43 (20-day SMA resistance)
• Critical support if bearish: $0.33 (strong technical support level)

Recent Polygon Price Predictions from Analysts

The recent analyst predictions from CoinArbitrageBot show a concerning disconnect from current market reality. While their MATIC price prediction models suggested targets between $0.21-$0.23 over the past week, MATIC has actually been trading 65-70% higher at $0.38. This significant variance highlights the challenges in short-term crypto forecasting.

However, the analysts’ methodology of identifying “sustained bullish momentum” and “positive market sentiment” aligns with our technical observation that Polygon has been holding above the critical $0.33 support level. The consensus prediction of gradual upward movement, while off on absolute price levels, correctly identified the underlying trend direction.

MATIC Technical Analysis: Setting Up for Consolidation Before Recovery

The current Polygon technical analysis reveals a cryptocurrency in transition. With MATIC trading at $0.38, the token sits precisely at its pivot point, suggesting a period of equilibrium between buyers and sellers. The RSI at 38.00 indicates oversold conditions without reaching extreme levels, providing room for recovery.

The MACD histogram showing -0.0045 confirms bearish momentum in the short term, but the relatively shallow negative reading suggests this selling pressure may be waning. More telling is MATIC’s position within the Bollinger Bands at 0.29, indicating the price is in the lower portion of its recent trading range but not at extreme oversold levels.

Volume analysis shows $1.07 million in 24-hour Binance spot trading, which represents moderate but not exceptional interest. This volume level suggests any breakout from current levels would need additional catalyst confirmation.

Polygon Price Targets: Bull and Bear Scenarios

Bullish Case for MATIC

Our primary MATIC price target focuses on the 20-day SMA at $0.43, representing a 13% gain from current levels. This Polygon forecast is based on the historical tendency for MATIC to find support at current levels and bounce toward moving average resistance.

The next major MATIC price target lies at the 7-day SMA of $0.37, which could act as initial resistance before the larger move to $0.43. Should momentum accelerate, the 50-day SMA at $0.45 becomes the medium-term objective, offering nearly 20% upside potential.

For the bullish case to materialize, MATIC needs to hold above the $0.35 immediate support level and show increasing volume on any upward moves. A break above $0.40 with conviction would confirm the recovery scenario.

Bearish Risk for Polygon

The downside MATIC price prediction centers on the $0.33 strong support level. A break below this critical level could trigger accelerated selling toward the 52-week low of $0.37 – though notably, current prices are already testing this historical floor.

The most concerning bearish scenario would see MATIC fall below $0.31, the lower Bollinger Band, which could indicate a breakdown toward the $0.25-$0.28 range. This would represent a 25-35% decline from current levels and would likely require broader crypto market weakness to materialize.

Risk factors include continued MACD deterioration, RSI falling below 30 into oversold territory, and any break below the immediate $0.35 support with significant volume.

Should You Buy MATIC Now? Entry Strategy

The current technical setup presents a mixed but potentially rewarding opportunity for those wondering whether to buy or sell MATIC. The optimal entry strategy involves a layered approach given the uncertain short-term direction.

For immediate entries, consider accumulating MATIC between $0.36-$0.38 with a tight stop-loss at $0.34. This provides a favorable risk-reward ratio targeting the $0.43 resistance level. More conservative investors should wait for either a clear break above $0.40 for momentum confirmation or a test of the $0.33 support for value entry.

Position sizing should remain modest given the current uncertainty, with no more than 2-3% of portfolio allocation recommended. The key is maintaining flexibility to add on strength above $0.40 or cut losses below $0.33.

MATIC Price Prediction Conclusion

Our comprehensive MATIC price prediction suggests a consolidation period followed by recovery toward $0.43-$0.45 over the next 4-6 weeks. While short-term bearish momentum creates near-term uncertainty, the technical foundation for Polygon forecast improvement remains intact.

The confidence level for this prediction is MEDIUM, given the mixed technical signals and broader crypto market volatility. Key indicators to watch include RSI movement above 45, MACD histogram turning positive, and sustained trading above the $0.40 level.

The timeline for this Polygon forecast centers on early January 2026, when year-end positioning effects should subside and clearer technical trends emerge. Failure to hold $0.33 support would invalidate this prediction and suggest deeper correction toward $0.25-$0.28 levels.

Image source: Shutterstock


Source link

Read More
19 12, 2025

CL=F $56, BZ=F $60 as Venezuela Blockade Meets Russia Sanctions

By |2025-12-19T02:49:47+02:00December 19, 2025|Forex News, News|0 Comments


Oil Price Today: WTI CL=F and Brent BZ=F Hover Near Multi-Month Lows

Spot Levels and Year-to-Date Damage for WTI CL=F and Brent BZ=F

Oil is weak, not collapsing. On 18 December 2025, WTI (CL=F) trades around $56–$57 and Brent (BZ=F) is near $60 per barrel. Intraday, Brent is up roughly 0.5–0.7% around $59.9–$60.1, while WTI adds about 0.7–1.0% near $56.3–$56.5, a modest bounce after WTI closed near $55.27 earlier in the week, its lowest settle since February 2021. Even after this uptick, 2025 remains a drawdown year: WTI is down roughly 21% year-to-date, and Brent is lower by just under 20%, consistent with a market that has been pricing oversupply and soft demand rather than a persistent shortage.

Geopolitics vs Glut: Blockade Noise, Russia Sanctions Risk and PDVSA Turmoil

Today’s modest rise is driven by a geopolitical risk premium, not by a structural tightening in balances. The United States has ordered a “total and complete blockade” of sanctioned tankers moving Venezuelan crude in and out of the country. Estimates suggest around 600,000 barrels per day of Venezuelan exports are potentially at risk, with flows to the U.S. of roughly 160,000 bpd still partially protected by authorizations linked to Chevron (NYSE:CVX) cargoes. Venezuelan flows represent roughly 1% of global supply, but sanctioned tonnage and insurance risk inject volatility into freight and risk pricing. At the same time, Venezuela’s PDVSA is recovering from a cyberattack that temporarily froze loadings. While operations have resumed, many export shipments remain delayed, adding another layer of uncertainty to short-term export volumes. Parallel to Venezuela, traders are watching the prospect of tighter U.S. sanctions on Russia’s energy sector if peace talks over Ukraine stall, plus new European measures targeting dozens of vessels in Russia’s “shadow fleet” designed to constrain sanctioned crude transport. In theory, these steps should be clearly bullish. In practice, the price impact is capped because the market’s dominant narrative is still “too much oil”, not “too little.”

Evidence of Oversupply: Inventories, Products and Oil on Water

Recent U.S. inventory data highlight the imbalance. Crude stocks fell by roughly 1.3 million barrels to about 424.4 million barrels in the week ending 12 December, but gasoline and distillate inventories rose more than expected. The crude draw is driven mainly by stronger exports and higher refinery runs, not by a surge in end-demand. Refinery utilization has climbed to the highest levels since early September, yet refined product stocks are building. That tells you the system is well supplied: refineries are processing heavily, but downstream demand is not tight enough to absorb output cleanly. Globally, official outlooks for 2025–2026 show demand growth around 830,000 bpd in 2025 and 860,000 bpd in 2026, while observed inventories rise and crude held “on water” increases sharply as cargoes take longer routes or sit waiting for buyers. Analyst scenarios for 2026 point to potential surpluses ranging roughly from 0.5 million bpd to over 4 million bpd, depending on how OPEC+, U.S. shale and new producers like Brazil, Guyana and Argentina behave. That is why every geopolitical shock is being faded: the default assumption is structural surplus, so disruptions must be large and prolonged to reprice the complex in a lasting way.

2026 Outlook for WTI CL=F and Brent BZ=F: Mid-$50s to Low-$60s Strip

Forward price projections for Brent (BZ=F) in 2026 cluster around the low-to-mid $50–$60 range, with WTI (CL=F) a few dollars lower. One major official U.S. forecast sees Brent averaging around $55 in Q1 2026 and staying close to that through the year. A large investment bank projects Brent around $56 and WTI near $52 in 2026, again reflecting depressed but not catastrophic pricing. A survey of analysts published recently shows Brent averaging about $62.2 and WTI around $59.0 in 2026. Different methodologies, similar conclusion: nobody is modeling a structurally tight oil market next year. Where they differ is timing of the turn. Several houses argue that by 2027 prices will need to move higher to incentivize new upstream investment as reserve life shrinks and U.S. shale matures, but the consensus is that 2026 itself is a low-pricing, surplus year, not a major bull market.

U.S. Shale, OPEC+ and the Pain Threshold Around $50 WTI CL=F

The WTI (CL=F) strip around $55–$57 is already uncomfortable for many producers. Internal modeling at major banks suggests that if WTI averages $57 in 2026, U.S. shale output could shrink by roughly 70,000 bpd instead of growing. Some official projections go further and flag a possible ~100,000 bpd drop in U.S. crude output in 2026 from 2025 levels as lower prices and a smaller rig fleet cap production. U.S. oil rig counts are down more than 15% from the start of the year and sit at their lowest since late 2021, consistent with a sector moving from “growth at any cost” to capital discipline. For many independents, WTI in the low-$50s is close to the point where protecting balance sheets takes priority over adding barrels. Even for supermajors, sustained prices near $50 compress returns on higher-cost projects. For OPEC producers, that price band is fiscally painful. This is why WTI around $50 is unlikely to be sustainable for long. Below that, a forced response is probable: deeper OPEC+ cuts, postponed projects, and a more aggressive capex reset in shale. The current strip fully prices a surplus, but it does not yet price a world where producers are forced into a meaningful supply contraction.

Demand Side for Oil: Weak Optics but No Structural Collapse Yet

On the demand side, the headline story is cautious: slower global growth, efficiency gains and the rise of alternatives. Yet several factors limit how bearish you can be. Earlier in 2025, tariff and trade-war risk was a major overhang. That pressure has eased after a new round of trade deals, reducing one large source of demand uncertainty. At the same time, fresh data show stronger fuel demand from India, which is now one of the key marginal buyers of crude globally. Forecasts that once called for oil demand to peak by the early 2030s have been pushed out. Some large institutions now expect demand to keep rising until at least 2040, albeit at a slower pace. This does not rescue 2026 – which still looks like “too much supply versus moderate demand growth” – but it clearly shows that long-term demand is not collapsing. The near-term tape is driven by inventory builds and oversupply; the long-term tape still has a clear consumption base.

Technical Structure: WTI CL=F Testing $55, Brent BZ=F Pinned at $60

Price action for WTI (CL=F) and Brent (BZ=F) fully reflects the fundamental picture: fragile bounces inside a broader downtrend. For WTI (CL=F), the $55 zone is the key short-term floor. A decisive break below $55 exposes the $52 region quickly, based on the next support band. Moves higher into the $58–$60 area are still being treated as rallies to sell, not as the start of a new uptrend, because there is no evidence yet of structural tightening in balances. For Brent (BZ=F), price is hovering around $60, which has become a pivot rather than a firm support. Repeated attempts to gap higher toward the low $60s have been sold off and quickly filled. A break below roughly $58 would likely drag Brent toward $55, consistent with the 2026 averages being projected. Momentum indicators and the pattern of failed bounces both point to a market trying to form a bottom but not confirmed. There is no technical validation of a bull phase until WTI can sustain trades above roughly $60 and Brent can push and hold into the mid-$60s. For now, the pattern remains sell-the-rally, not buy-the-dip.

Forward Curve, Producer Sentiment and the Floor-Versus-Ceiling Dynamic

The forward curve reinforces this picture. The strip implies Brent (BZ=F) in the mid-$50s to low-$60s and WTI (CL=F) in the low-to-high-$50s for 2026, matching the bulk of published forecasts. Industry executives are guiding for another dull year in 2026 with low prices, muted upstream spending and limited growth in production. At the same time, large integrated producers are clear that prices at this level are not viable indefinitely if the world wants stable supply into the 2030s. Stronger balance sheets at names like Exxon Mobil (NYSE:XOM) and Chevron (NYSE:CVX) allow them to operate through this strip, but they will not rush to sanction expensive long-cycle projects until pricing improves. Smaller shale operators are already throttling activity, which is why several projections show U.S. output potentially dipping next year despite sizeable resources. This creates a floor-versus-ceiling regime: the floor is set by the point at which producers start cutting supply aggressively, likely the low-$50s WTI / low-$50s Brent band, and by geopolitical risk around Russia and Venezuela; the ceiling is imposed by high inventories, surging oil on water and credible surplus forecasts that make every spike look like a selling opportunity.

Investment View on WTI CL=F and Brent BZ=F: Tactical Bearish, Strategic Hold

Combining spot, fundamentals, technicals and the curve leads to a clear stance on WTI (CL=F) and Brent (BZ=F) at current prices. With WTI around $56–$57 and Brent near $60, the market is trading close to the center of the 2026 forecast range. Supply-demand projections and inventory trends argue that oversupply will keep rallies capped through most of 2026 unless there is a large, sustained disruption. At the same time, prices much below $50 WTI / low-$50s Brent would almost certainly force a supply reaction from U.S. shale and OPEC+, and most serious outlooks are already baking in some degree of restraint. Based on the data, the view is: near term (next 6–12 months), tactical bias is bearish, with strength into roughly $60+ WTI / mid-$60s Brent still better used for selling rather than chasing. Over 12–24 months, stance is HOLD on crude benchmarks: the downside toward the low-$50s is real as long as the surplus story dominates, but structural under-investment and maturing shale give a credible path back into the $65–$75 Brent zone later in the decade.

That’s TradingNEWS






Source link

Read More
19 12, 2025

New Weight Loss Pill Could Burn Fat Without Muscle Loss

By |2025-12-19T02:08:37+02:00December 19, 2025|Dietary Supplements News, News|0 Comments


GLP-1 style treatments like Ozempic and Mounjaro are doing wonders when it comes to helping people lose unwanted bodyfat, but research indicates that lean mass could also fall thanks to GLP-1, leading to an almost 40% drop in skeletal muscle in some cases. That’s why news of a new drug that can burn fat while preserving muscle could be a game changer, even complimenting existing treatments.

Encouraging results from a study on the new drug, known technically as a “GRK-biased adrenergic agonist,” have been extremely promising. Firstly, it’s available as an oral pill, meaning no nasty needles, and secondly, this compound doesn’t act on hunger levels. GRK-biased drugs boost metabolic activity within the muscle instead of encouraging appetite loss.

What do we know so far about Compound 15?

Results from an important study that came as a result of work by the Karolinska Institutet and Stockholm University, both in Sweden, were recently published in the Cell Press journal, and come from an important phase I clinical trial involving 48 healthy volunteers alongside 25 individuals with type 2 diabetes, showing that it could lower blood pressure and increase fat burning capabilities within the body, leading to longer lives.

The active substance in this novel drug is a lab developed compound dubbed “Compound 15,” that benefits muscle function but doesn’t overstimulate the heart. “Our results point to a future where we can improve metabolic health without losing muscle mass,” explained Tore Bengtsson, who is professor at the Department of Molecular Bioscience, Wenner-Gren Institute, Stockholm University.  And that’s important, because “muscle mass is also directly correlated with life expectancy,” he added.

Because Compound 15 works via a different pathway to GLP-1 treatments, it may be effective as a standalone drug or paired with others like Ozempic or Mounjaro for supercharged results. So, for those who have shunned GLP-1s because of needles and the potential effects on muscle mass, this is seriously great news. “This drug represents a completely new type of treatment and has the potential to be of great importance for patients with type 2 diabetes and obesity,” said Shane C. Wright, who is an assistant professor at the Department of Physiology and Pharmacology at Karolinska Institutet. “Our substance appears to promote healthy weight loss, and, in addition, patients do not have to take injections.”

When will Compound 15 be made available to the public?

Experts say the next phase in rolling out the miracle drug will depend on a larger, phase II clinical trial, but medical practitioners and those who like to stay in shape are already excited for the prospect of an obesity or type 2 diabetes drug that can protect muscle, especially concerning the recent news that Metformin, another popular type 2 diabetes treatment, can potentially undermine the benefits of exercise.



Source link

Read More
19 12, 2025

Dogecoin Price Prediction: DeepSnitch AI Surges 85% as T1 CEX Listing Rumors Start Spreading

By |2025-12-19T02:02:38+02:00December 19, 2025|Crypto News, News|0 Comments

Solana just launched a quantum-resistant testnet with Project Eleven, aiming to future-proof its blockchain against quantum threats. While the tech is impressive, the market didn’t seem to care as Solana’s price barely moved.

That’s because investors have their eyes elsewhere. DeepSnitch AI’s presale is gaining attention with $825K+ raised, and actual AI tools live before launch. Regardless of Dogecoin price predictions, DeepSnitch AI might be the next altcoin to hit $1 in 2026.

Solana launches quantum-resistant testnet

The Solana Foundation has partnered with security firm Project Eleven to test quantum-resistant cryptography on a dedicated Solana testnet. The pilot uses post-quantum digital signatures to complete fully on-chain transactions.

The move comes amid growing concern over the long-term threat of quantum computers breaking current cryptographic standards. While some experts like Vitalik Buterin suggest this could happen by 2030, others argue it’s still decades away.

Solana’s testnet is part of its broader mission to future-proof its blockchain, though it has not confirmed which encryption standard was used.

Top 3 altcoins to buy in 2025

DeepSnitch AI

DeepSnitch AI was made for traders who are tired of being the exit liquidity. If you’ve ever felt like you were two steps behind the big players, DeepSnitch AI is your way to catch up, and maybe even beat them.

That edge could be critical heading into 2026. With the FED cutting rates in October and December, the stage is set for a massive crypto rally. And it’s pretty clear that the AI + crypto sector is going to lead it. Gartner’s $1.5 trillion forecast for AI spending in 2025 says it all.

Three of its five planned AI agents are already working in the background. SnitchScan checks contracts for hidden traps. SnitchFeed watches whale wallets and alerts you when they move. SnitchGPT gives you market answers with a simple text prompt.

With a current presale price of just $0.02846, DSNT is capable of outperforming any Dogecoin price prediction. More than $825,000 has already been raised, over 20 million tokens are staked, and Tier 1 listing rumors are swirling ahead of the January launch. Now is the last time you can catch DSNT at an early valuation.

Dogecoin price prediction: Can DOGE return to $0.2?

Dogecoin was sitting at around $0.13 on December 17. Support at $0.128 is holding, but momentum is fading. According to a popular Dogecoin price prediction, if that level breaks, the price may drop toward $0.10. A move above $0.15 could flip sentiment bullish again.

But there’s a problem: DOGE spot ETFs are failing to impress. Since launching on November 30, they’ve pulled in just $2.16M, only 0.03% of DOGE’s market cap. On December 16, they had zero inflows, while Solana brought in $3.64M and Chainlink $1.38M. Daily volumes hover around $49K. Traditional investors aren’t investing in meme coins; they prefer tokens with utility.

That’s why the Dogecoin price predictions remain flat while DeepSnitch AI is aiming for the 100x returns. The AI protocol is offering something nobody could have before: an intelligence layer that can offer retail traders the same insights institutions have.

Solana’s price consolidates despite a positive update from Charles Schwab

SOL was holding near $127 on December 17, a strong support zone. Buyers are stepping back in, and a cup-and-handle pattern is forming. A breakout above $128 could send SOL toward $135 or even $200 if momentum builds.

Charles Schwab added SOL futures to its platform, giving institutional players a way to trade Solana without touching the token itself. This move mirrors what happened with Bitcoin in 2017 and Ethereum in 2021, the moment they became part of traditional finance.

With Schwab in the game, hedge funds and asset managers can now join in without custody risks. That brings more capital and changes how SOL trades. It’s no longer just about spot demand.

The bottom line

The Dogecoin price prediction might still look bullish on the surface, but the meme magic is wearing thin. ETF flows are weak, and investors are shifting toward tokens with genuine utility. That’s exactly where DeepSnitch AI comes in.

With three live AI agents and over $825K already raised, DSNT is creating a new trend. Whales are already stacking at $0.02846, and now’s your chance to get in early, with DSNTVIP50 or DSNTVIP100 unlocking up to 100% bonus tokens.

Visit the official DeepSnitch AI website, join Telegram, and follow on X (Twitter) for the latest updates.

FAQs

Is DeepSnitch AI a better investment than the current DOGE future projection?

Yes. While the DOGE future projection looks uncertain due to weak ETF flows, DeepSnitch AI is offering stronger fundamentals and higher upside going into 2026.

Can DeepSnitch AI outperform Dogecoin bullish momentum in 2026?

Absolutely. Dogecoin bullish momentum is slowing, but DeepSnitch AI is positioned to outperform DOGE in both utility and price growth.

Are there stronger DOGE adoption signals or does DeepSnitch AI lead?

Right now, DeepSnitch AI shows clearer adoption signals. DOGE ETF inflows remain low, while DSNT has over $825K raised and a working AI dashboard already live.

 

Source link

Read More
19 12, 2025

Natural Gas Price Forecast: Rally Fails at $4.22 – Bear Engulfing Targets $3.84

By |2025-12-19T00:48:35+02:00December 19, 2025|Forex News, News|0 Comments


Resistance Confirmation

Today’s bearish behavior adds to the likelihood that the next lower key support zone may be reached before the current retracement completes. The 61.8% Fibonacci retracement at $3.89 defined this week’s support zone. The reaction of price resistance represented by the 50-day line and a top channel line has shown the sellers remaining in charge. The two indicators show a similar price area for resistance and today’s bearish reaction confirms it. Once prior key support is shown as resistance, the downtrend may be ready to proceed. However, a drop below and daily close below this week’s low of $3.84 is still needed for a bearish continuation signal.

Deeper Support Targets

If natural gas fails to take out today’s high before a new trend low, then the next lower target looks likely to be reached. The 200-day average at $3.58 anchors the next lower price zone, along with a long-term uptrend line and a horizontal level around $3.59. That price area was shown as both clear support and resistance in the past. Most recently with the October high at $3.59.

More significantly, the 2023 peak was at $3.64. If that zone fails to reverse price, then the 78.6% Fibonacci retracement at $3.45 becomes a target. There is also confirmation for the 200-day price zone in the weekly chart as the 50-week and 20-week averages are at $3.63 and $3.61, respectively.

Upside Reversal Requirements

On the upside, a decisive breakout above today’s high would be needed for a bullish reversal. That would put natural gas in a position to challenge resistance near the 20-day average, now at $4.55 and falling.

Outlook

Natural gas’s bounce has stalled exactly at flipped support with a bearish engulfing pattern, reinforcing seller dominance and raising odds of a confirmed break below $3.84. Hold above today’s high to keep countertrend hopes alive; failure opens acceleration toward the powerful 200-day confluence at $3.58–$3.64 and potentially $3.45 if that breaks.



Source link

Read More
19 12, 2025

GBPUSD Forecast: British Pound Battles “Moving Average Cluster” After Hawkish BoE Cut

By |2025-12-19T00:16:34+02:00December 19, 2025|Forex News, News|0 Comments

The GBPUSD pair has transformed into a technical battleground as the trading week nears its close. A combination of a divided Bank of England (BoE) and a cooling US inflation report has created a “whipsaw” environment, leaving the price resting precariously on a significant layer of technical support.

  • The BoE Catalyst: A narrow 5-4 vote for a “hawkish cut” by the Bank of England initially sparked Sterling strength, signaling that the path to future rate cuts remains steep.

  • The CPI Whipsaw: A soft US CPI print (2.7%) sent the pair to a multi-week high of 1.3446 before a massive retracement saw the pair surrender all daily gains.

  • The Technical Floor: The price is currently testing a “cluster” of four major moving averages between 1.3348 and 1.3380, a zone that will define the trend for the Friday close.

Breaking Down the Momentum: From Hawkish Cuts to Soft CPI

The initial leg of the GBPUSD rally was fundamentally driven. The Bank of England’s decision to cut rates—but with a clear 5-4 split—indicated to the markets that the BoE is not in a rush to ease aggressively. This “hawkish lean” gave the British Pound a head start against a softening Greenback.

Later, the US Consumer Price Index (CPI) added fuel to the fire. The weaker-than-expected inflation data triggered a sharp sell-off in the US Dollar, propelling the “Cable” above a series of key daily and hourly moving averages. This move saw the pair challenge the highs of the last two weeks, specifically testing the Tuesday peak near 1.3455.

The “Moving Average Cluster” Barometer

Despite the breakout, momentum failed to hold. The pair has retraced back into a dense zone where four critical moving averages are currently overlapping. This “cluster” acts as a massive technical pivot point:

As long as the price remains within or above this zone, the “Up and Down” volatility theme persists. The price action today reached as low as 1.3370 before stabilizing slightly, keeping the market in a state of high suspense.

The Roadmap: What to Watch for the Friday Close

As we transition into the final session of the week, the cluster of moving averages will serve as the primary barometer for directional bias.

The Bullish Scenario

For the buyers to reclaim the driver’s seat, they must keep the price sustained above the 1.33804 (100-hour MA). A push above the 1.3405 swing area is required to confirm that the bears have been flushed out. If successful, the door opens for another run toward the recent highs at 1.34526.

The Bearish Scenario

If the sellers gain enough traction to break below the bottom of the cluster at 1.33488 (200-day MA), the technical picture turns decidedly bearish. A break here would likely trigger a retest of the weekly low at 1.33118, with a secondary target at last week’s low and the key 38.2% Fibonacci retracement level of 1.32833.

Watch the Video Analysis

In the video above, Greg Michalowski, author ofAttacking Currency Trends, provides a deep dive into these GBPUSD technical levels. He breaks down the real-time price action, helps you define the bias, the risk, and the specific targets that will matter most today and going forward.

Be aware. Be prepared.

Source link

Read More
19 12, 2025

Synaptigen Review: Ingredients, Benefits, Safety, and Who It’s For – On Pattison

By |2025-12-19T00:07:34+02:00December 19, 2025|Dietary Supplements News, News|0 Comments


 

Synaptigen Review: An In-Depth Look at the Ingredients, Intended Benefits, and Who It May Be For

 

This article is provided for educational and informational purposes only and is not intended to replace individualized medical, nutritional, or professional advice. Many factors, including age, genetics, lifestyle, medications, and underlying health conditions can influence cognitive health. Readers are encouraged to consult a qualified healthcare professional before starting any new dietary supplement, especially if they are pregnant, nursing, taking medication, or managing a medical condition.

 

Synaptigen is a dietary supplement, not a medication. Statements about ingredients discussed in this article are based on publicly available research and are presented for general educational context only. Synaptigen as a finished product has not been clinically evaluated by the FDA, and individual results may vary.


 

Throughout this report, all product features, pricing, guarantees, and policies are attributed directly to the company’s official website as of publication and are subject to change. Readers are encouraged to verify details directly with the brand before making any purchase decisions.

 

Disclosure: If you register through this link, a commission may be earned at no additional cost to you.

 

Why Cognitive Changes Feel So Frustrating — And Why Many People Start Looking for Support


 

For many people, changes in memory, focus, or mental sharpness don’t happen all at once. They tend to show up quietly — a forgotten name here, a moment of mental fog there, or a growing sense that staying mentally sharp now takes more effort than it used to.

 

What often makes this experience frustrating isn’t just the change itself, but the uncertainty around it. Is this simply part of normal aging? Is it related to stress, sleep, nutrition, or daily habits? Or is it something that could potentially be supported with the right lifestyle adjustments and nutritional choices?

 

For readers actively searching for answers, the challenge isn’t a lack of options — it’s too many conflicting claims. Some products promise dramatic outcomes. Others lean heavily on scientific jargon without explaining what it actually means for everyday cognitive function. And many leave readers unsure where ingredient research ends and marketing language begins.


 

That gap is exactly where interest in cognitive-support supplements like Synaptigen tends to emerge.

 

Rather than positioning itself as a quick fix, Synaptigen is presented by the company as a daily brain-support formula designed to help maintain memory, focus, and mental clarity over time. The brand’s messaging emphasizes support, nourishment, and long-term cognitive maintenance — concepts that resonate with people who want to stay proactive about brain health without jumping to extreme solutions.

 

What Is Synaptigen? A Brand-Positioned Overview


 

Synaptigen is a dietary supplement marketed by its manufacturer as a daily cognitive support formula intended to help maintain memory, focus, and overall mental clarity as part of a long-term wellness routine.

 

According to the company, Synaptigen is designed for adults who are interested in supporting normal brain function through nutrition rather than relying solely on stimulants or short-term cognitive enhancers. The product is positioned around the idea that brain health, like physical health, benefits from consistent nutritional support over time, especially as natural changes occur with age.

 

The brand states that Synaptigen’s formula combines probiotics, prebiotics, and plant-derived nutrients in a single, easy-to-use tablet. Rather than focusing on immediate stimulation, the company frames its approach around supporting the internal environment in which brain cells function, with an emphasis on nourishment and maintenance.


 

Importantly, Synaptigen is presented as a dietary supplement, not a medication. The company does not describe it as a treatment, therapy, or cure for any medical condition. Instead, it is intended to complement healthy lifestyle habits such as balanced nutrition, adequate sleep, physical activity, and stress management.

 

From a formulation standpoint, the brand highlights several characteristics that may appeal to certain consumers, including:

 

  • Natural, non-GMO ingredients, according to the company
  • No added stimulants, which may be relevant for individuals sensitive to caffeine or similar compounds
  • A once-daily, melt-in-the-mouth tablet, designed for convenience and ease of use

 

As with any supplement, whether Synaptigen is an appropriate choice depends on individual needs, expectations, and health considerations. Understanding how the company says the formula is structured — and how its ingredients are intended to play a role — is a necessary next step before evaluating fit.


 

A Closer Look at the Ingredients in Synaptigen

 

To evaluate any cognitive support supplement responsibly, it’s important to separate ingredient research from product-level claims. What follows is a high-level overview of the individual ingredients listed by the company, along with context on how these ingredients are generally discussed in scientific and nutritional literature.

 

This section is intended for educational purposes only. While certain ingredients have been studied independently, Synaptigen as a finished product has not been clinically studied, and outcomes can vary from person to person.


 

Probiotic Strains

 

According to the company, Synaptigen includes several probiotic strains selected for their potential role in supporting gut health, which some research suggests may be connected to broader neurological and cognitive processes through the gut–brain axis.

 

Lactobacillus paracasei

 

This probiotic strain is commonly studied for its role in digestive balance and immune system interaction. In ingredient-level research, Lactobacillus paracasei has been explored for how gut microbiota may influence inflammation and metabolic signaling — factors that researchers believe can indirectly affect overall brain function.

 

Lactobacillus reuteri

 

Lactobacillus reuteri is another well-researched probiotic strain. Ingredient studies often examine its role in maintaining gut lining integrity and supporting balanced microbial populations. Some researchers have investigated how these functions may contribute to general neurological signaling through gut–brain communication pathways, though these effects are not specific to any single supplement.

 

Bifidobacterium lactis BL-04

 

This strain is frequently included in probiotic formulations and is typically studied for immune support and digestive comfort. Ingredient-level literature suggests that balanced gut bacteria may play a role in how the body manages stress responses and inflammatory markers, which are areas of interest in broader cognitive health research.

 

Prebiotic Support

 

Inulin

 

Inulin is a naturally occurring prebiotic fiber that serves as a food source for beneficial gut bacteria. Research at the ingredient level shows that prebiotics like inulin can help support the growth and activity of probiotics, potentially enhancing their ability to contribute to overall gut balance. A healthier gut environment is often discussed in research as one factor that may influence mental clarity and overall wellness.

 

Mineral and Plant-Based Components

 

Tricalcium Phosphate

 

Tricalcium phosphate is commonly used in supplements as a source of calcium and as a stabilizing or anti-caking agent. Calcium plays a recognized role in normal nerve signaling and cellular communication, though its inclusion in supplements is generally intended to support overall nutritional balance rather than produce targeted cognitive effects.

 

Strawberry Extract

 

Plant extracts like strawberry extract are often included for their naturally occurring phytonutrients and antioxidant compounds. Ingredient research into berries frequently focuses on how antioxidants may help protect cells from oxidative stress, a process that is widely studied in relation to aging and general brain health.

 

Peppermint Extract

 

Peppermint extract is traditionally associated with digestive comfort and sensory alertness. Some ingredient-level studies explore peppermint’s aromatic and phytochemical properties in relation to mental alertness and perceived clarity, although effects can be subjective and vary between individuals.

 

Important Context for Readers

 

While each of these ingredients has been studied individually in different contexts, it’s important to emphasize that ingredient research does not automatically translate to product-specific outcomes. The way ingredients interact within a proprietary blend, individual biology, dosage, and consistency of use all influence how a supplement may be experienced.

 

This is why responsible evaluation goes beyond ingredient lists alone. Understanding how the brand positions the overall formula, how it is intended to be used, and who it may or may not be appropriate for is just as important as reviewing the components themselves.

 

Read More: Gut-Brain Probiotic Supplement for Digestive Comfort, Mental Clarity, and Long-Term Wellness

 

How Synaptigen Is Designed to Be Used

 

According to the company, Synaptigen is intended to be used as a once-daily cognitive support supplement, incorporated into a consistent wellness routine rather than taken on an as-needed basis.

 

Daily Use Format

 

Synaptigen comes in a melt-in-the-mouth tablet, which the brand states can either be allowed to dissolve slowly or gently chewed. This delivery format is positioned as a convenience feature, particularly for individuals who prefer not to swallow traditional capsules.

 

Per the official website, the recommended usage is:

 

  • One tablet per day
  • Taken consistently as part of a daily routine

 

The company does not promote Synaptigen as a stimulant or quick-acting cognitive enhancer. Instead, it is framed as a supplement designed to support ongoing cognitive maintenance over time when used regularly.

 

Setting Realistic Expectations

 

One of the most important considerations with any dietary supplement is understanding what it is — and what it is not.

 

Synaptigen is not positioned as a medication, treatment, or therapy for cognitive conditions. The brand does not state that it diagnoses, treats, cures, or prevents any disease. Rather, it is presented as a nutritional option for adults who want to be proactive about supporting memory, focus, and mental clarity as part of a broader lifestyle approach.

 

As with most supplements, individual experiences may vary based on factors such as:

 

  • Age and baseline cognitive health
  • Diet and nutrient status
  • Sleep quality and stress levels
  • Consistency of use
  • Medications or underlying health conditions

 

For this reason, the company emphasizes ongoing use rather than immediate or dramatic effects. Readers evaluating Synaptigen may want to think in terms of gradual support and maintenance, not instant changes.

 

Who This Usage Style May Appeal To

 

The simplicity of a once-daily tablet may be appealing to people who:

 

  • Prefer low-effort routines
  • Want to avoid caffeine or stimulant-based products
  • Are looking for a supplement that fits into long-term wellness habits rather than short-term performance goals

 

At the same time, individuals seeking rapid or noticeable cognitive effects in the short term may find that a daily support supplement does not align with their expectations.

 

Who Synaptigen May Be Right For

 

Choosing a cognitive support supplement is a personal decision, and no single product is an ideal fit for everyone. Rather than relying on testimonials or generalized claims, a self-assessment approach can help readers decide whether Synaptigen aligns with their needs and expectations.

 

Synaptigen May Align Well With People Who:

 

  • Are looking to support memory and focus as part of long-term wellness: Individuals who view cognitive health as something to maintain gradually — similar to physical fitness — may appreciate a supplement positioned around daily nutritional support rather than quick stimulation.
  • Prefer non-stimulant cognitive support options: According to the company, Synaptigen does not contain added stimulants. This may be relevant for people who are sensitive to caffeine or prefer to avoid products that can interfere with sleep or cause jitteriness.
  • Value gut-health-oriented approaches to overall wellness: Readers interested in the gut–brain connection and the potential role of probiotics and prebiotics in broader wellness routines may find the formulation concept aligns with their interests.
  • Want a simple, once-daily routine: The melt-in-the-mouth tablet format and once-per-day usage may appeal to those who prefer minimal complexity in their supplement regimen.

 

Other Options May Be Preferable For People Who:

 

  • Are seeking rapid or dramatic cognitive changes: Synaptigen is not positioned as a fast-acting or performance-enhancing product. Individuals looking for immediate or highly noticeable effects may want to explore other approaches with their healthcare provider.
  • Have diagnosed cognitive or neurological conditions: People managing medical conditions related to memory or cognition should consult a qualified healthcare professional before considering any supplement, as Synaptigen is not intended to diagnose, treat, or manage disease.
  • Prefer products with clinically studied finished formulations: While individual ingredients have been researched, Synaptigen as a complete product has not been clinically studied. Readers who prioritize finished-product clinical trials may wish to factor this into their decision.

 

Questions to Ask Yourself Before Deciding

 

  • Am I looking for ongoing support rather than a quick solution?
  • Do I understand the difference between ingredient research and product-specific evidence?
  • Am I willing to use a supplement consistently as part of a broader lifestyle approach?

 

Taking the time to answer these questions honestly can help clarify whether Synaptigen fits your expectations — or whether another approach might be more appropriate.

 

Synaptigen Pricing, Bundles, and What the Company Offers

 

Pricing transparency is an important part of evaluating any dietary supplement, especially in high-YMYL categories like cognitive health. All pricing and bundle information below is attributed to the company’s official website and reflects how Synaptigen is presented to consumers at the time of publication.

 

Available Purchase Options

 

According to the company, Synaptigen is sold in multi-bottle packages, with pricing structured to encourage longer-term use rather than single short trials. The brand states that the following options are typically available:

 

  • Smaller multi-bottle option: Priced at $79 per bottle, positioned for those who want to try the product before committing to longer-term use.
  • Mid-range bundle: Priced at $69 per bottle, often presented as a balance between upfront cost and longer usage.
  • Best-value bundle: Priced at $49 per bottle, offered with a larger quantity and positioned by the company as its recommended option for extended use.

 

The company emphasizes that pricing is per bottle, and total order cost depends on the bundle selected at checkout. Readers are encouraged to review current pricing directly on the official website, as promotions and availability may change.

 

For readers who want to verify current bundle options or see what is currently available, Synaptigen can be found through the company’s official checkout page.

 

Bonuses and Shipping 

 

Per the official website, larger bundle purchases may include digital bonus materials at no additional charge. These bonuses are informational guides focused on topics such as sleep habits, learning strategies, and memory techniques. The company presents these as educational resources rather than medical programs.

 

The brand also states that:

 

  • Free shipping is typically offered on larger orders within the United States
  • International shipping is available for select regions, with additional fees and longer delivery times

 

Shipping timelines and fees vary by location and are displayed during checkout.

 

Refund Policy Overview

 

According to the company, Synaptigen purchases are covered by a 180-day refund policy. The brand states that customers who are not satisfied may request a refund within this period by returning their order in accordance with the company’s published refund instructions.

 

As with any purchase, readers are encouraged to review the full refund and return policy directly on the official website to understand all requirements and conditions before ordering.

 

Pricing Disclaimer: All prices and offers were accurate at the time of writing (December 2025) and are subject to change at the company’s discretion.

 

Included Bonus Materials: What the Company Says Is Offered

 

In addition to the supplement itself, the company states that certain Synaptigen bundle options may include digital educational materials provided at no additional charge. These bonuses are presented as general informational guides rather than medical or therapeutic programs.

 

Bonus #1: Deep Sleep Blueprint

 

According to the company, this digital guide focuses on sleep-related habits and routines intended to support better rest. The material is described as covering topics such as:

 

  • Environmental adjustments related to sleep comfort
  • Common lifestyle habits that may influence sleep quality
  • General relaxation and wind-down techniques

 

This guide is positioned as educational content, not as a treatment for sleep disorders or medical conditions.

 

Bonus #2: Sharp Mind in 7 Days

 

The company describes this bonus as an informational resource that explores learning techniques and mental habits. Topics are said to include:

 

  • Memory and recall strategies used in educational contexts
  • Simple cognitive exercises designed to encourage mental engagement
  • Everyday practices that may support mental clarity

 

Despite the title, this guide is not presented as a guarantee of results within a specific timeframe. Individual experiences with educational strategies can vary widely.

 

Bonus #3: 10 Proven Ways to Learn Faster and Boost Memory

 

Per the official website, this bonus focuses on learning and memory techniques commonly discussed in cognitive psychology and educational research. The material is described as highlighting:

 

  • Mnemonics and associative learning concepts
  • Visualization-based memory strategies
  • Habit-based approaches to skill and knowledge retention

 

As with the other bonuses, this guide is informational in nature and does not replace professional educational or medical advice.

 

Important Context About Bonuses

 

It’s important for readers to understand that:

 

  • These bonuses are digital informational resources, not supplements or medical programs
  • They are provided at the company’s discretion and may change over time
  • Access is typically delivered electronically following purchase

 

While some readers may find these materials helpful as part of a broader learning or wellness routine, they should not be interpreted as diagnostic, therapeutic, or outcome-based tools.

 

Frequently Asked Questions About Synaptigen

 

How does Synaptigen work, according to the company?

 

According to the company, Synaptigen is designed as a daily dietary supplement that supports memory, focus, and mental clarity through a combination of probiotics, prebiotics, and plant-derived nutrients. The brand frames its approach around supporting internal systems that are involved in normal brain function rather than providing stimulation or acting as a treatment for any condition.

 

Any references to how the product is “designed to work” reflect the company’s intended formulation philosophy and should not be interpreted as guaranteed outcomes.

 

Is Synaptigen a medication or medical treatment?

 

No. Synaptigen is marketed as a dietary supplement, not a medication. The company does not position it as a treatment, therapy, or cure for any disease or medical condition. Individuals with health concerns related to cognition should consult a qualified healthcare professional before using any supplement.

 

How do I take Synaptigen?

 

Per the official website, Synaptigen is taken once per day in the form of a melt-in-the-mouth tablet. The tablet can be allowed to dissolve slowly or gently chewed. Consistent daily use is emphasized by the company as part of a long-term wellness routine.

 

How long does it take to notice changes?

 

The company does not provide a specific timeline for when individuals may notice changes. As with most dietary supplements, individual experiences can vary based on factors such as age, diet, lifestyle, and consistency of use. Readers are encouraged to approach Synaptigen with realistic expectations and to avoid assuming immediate effects.

 

Does Synaptigen contain stimulants?

 

According to the company, Synaptigen does not contain added stimulants. This may be relevant for individuals who prefer cognitive support options that do not rely on caffeine or similar compounds.

 

Is Synaptigen a subscription or recurring charge?

 

The company states that Synaptigen is offered as a one-time purchase, not an automatic subscription. Customers are encouraged to review checkout details carefully to confirm current purchase terms before completing an order.

 

What is the refund policy?

 

According to the company, Synaptigen purchases are covered by a 180-day refund policy, subject to the brand’s published return requirements. Readers should review the full refund policy on the official website to understand eligibility, timelines, and return procedures.

 

Where can I purchase Synaptigen?

 

Synaptigen is sold directly through the company’s official website. For those who want to review current offers or verify availability, the product can be accessed through the official Synaptigen ordering page.

 

Final Verdict: A Measured Look at Synaptigen

 

Synaptigen is positioned by its manufacturer as a daily cognitive support supplement intended for adults who want to take a proactive, nutrition-based approach to maintaining memory, focus, and mental clarity over time.

 

Rather than emphasizing stimulation or rapid effects, the company frames Synaptigen around long-term support and consistency, using a blend of probiotics, prebiotics, and plant-derived ingredients. This approach may appeal to individuals who are interested in the broader concept of gut–brain balance and who prefer supplements that fit into everyday wellness routines without added stimulants.

 

At the same time, it’s important to recognize the limitations that come with any dietary supplement. While individual ingredients included in Synaptigen have been studied in various contexts, the product itself has not been clinically evaluated as a finished formulation, and individual experiences can vary significantly. Synaptigen is not intended to diagnose, treat, cure, or prevent disease, and it should not be viewed as a substitute for medical care.

 

From a practical standpoint, the once-daily tablet format, non-stimulant positioning, and availability of longer-term bundle options may be appealing for certain users. Others — particularly those seeking immediate cognitive changes or products backed by finished-product clinical trials — may find that alternative approaches are more appropriate.

 

Ultimately, Synaptigen appears best suited for readers who:

 

  • Understand the difference between ingredient research and product-specific evidence
  • Are comfortable with gradual, maintenance-oriented support
  • Want a supplement that complements broader lifestyle habits rather than replaces them

 

As with any wellness decision, reviewing the full product details, policies, and ingredient information directly with the company — and consulting a healthcare professional when appropriate — can help ensure that expectations align with reality.

 

For readers who wish to explore current offers or review the company’s full disclosures, Synaptigen is available through the official website.

 

Contact Information (Company-Provided)

 

For product-specific questions, shipping inquiries, or refund requests, the company lists the following contact details:

  

Important Disclaimers and Disclosures

 

  • FDA Health Disclaimer: These statements have not been evaluated by the Food and Drug Administration. Synaptigen is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease.
  • Professional Medical Disclaimer: The information provided in this article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.
  • Ingredient Research Disclosure: Research discussed in this article relates to individual ingredients only. Synaptigen, as a finished product, has not been clinically studied. Outcomes may vary depending on individual health factors, consistency of use, and lifestyle variables.
  • Results May Vary: Individual experiences with dietary supplements can vary significantly based on age, baseline health, diet, genetics, medications, and other factors. No specific results are guaranteed.
  • Affiliate Disclosure: This article contains affiliate links. If you choose to make a purchase through these links, a commission may be earned at no additional cost to you. This helps support independent research and editorial efforts.
  • Pricing Disclaimer: All pricing, bundle offers, and promotional details were accurate at the time of publication (December 2025) and are subject to change. Always verify current pricing and policies directly on the company’s official website.

   



Source link

Read More
19 12, 2025

XRP Price Prediction: XRP Flashes Oversold Reversal Signals as RSI Drops to 33 and Key Support Holds

By |2025-12-19T00:01:24+02:00December 19, 2025|Crypto News, News|0 Comments

XRP is back in focus as mounting selling pressure pushes key momentum indicators into oversold territory, raising fresh debate over whether the market is nearing a short-term turning point.

XRP is drawing renewed attention from market participants as market structure and momentum metrics indicate the asset may be approaching a critical inflection point. After a steady decline over the past week, XRP is trading near $1.88, reflecting a 1.41% daily drop, while maintaining strong liquidity with more than $3.5 billion in 24-hour trading volume.

XRP RSI Hits Oversold Territory as Price Tests Key Support

Crypto analyst Good Evening Crypto (@AbsGMCrypto) highlighted the oversold condition in a recent post, stating, “BREAKING: $XRP WEEKLY RSI HITS 33! Could see a large bounce from these ranges…”

XRP weekly RSI hits 33, signaling a potential bounce from oversold levels. Source: @AbsGMCrypto via X

According to commonly observed TradingView market data trends, similar weekly RSI levels have marked key turning points during prior cycles. During the 2017–2018 bull run, XRP advanced from approximately $0.20 to $3.40 after extended periods of oversold conditions. A comparable setup appeared in November 2024, when subdued momentum preceded a 580% rally that peaked in early 2025.

While historical patterns can provide context, they do not guarantee similar outcomes. Nevertheless, the recurrence of these signals has kept XRP under close observation among technically focused traders.

Analysts Identify $1.83–$1.90 as a Crucial XRP Support Zone

Short-term market behavior indicates XRP is attempting to stabilize above a well-defined technical area. The asset recently dipped into the $1.83–$1.87 range, a zone that has attracted consistent buying interest in recent sessions.

XRP Price Prediction: XRP Flashes Oversold Reversal Signals as RSI Drops to 33 and Key Support Holds

XRP shows a bullish reaction from key support, with momentum favoring an upside move toward near-term technical targets. Source: ExpertTraderASK on TradingView

TradingView analyst ExpertTraderASK described the setup as constructive on lower timeframes: “Price is showing a strong bullish reaction from a critical support zone; momentum favors the upside on the 15M timeframe.”

The analyst outlined near-term technical targets at $1.8830, $1.8990, and $1.9230, while emphasizing the importance of disciplined position sizing and stop-loss management. This intraday optimism contrasts with higher-timeframe structures that continue to point toward consolidation rather than a confirmed trend reversal.

Long-Term Chart Signals Mixed Outlook for XRP

From a broader perspective, crypto strategist EGRAG CRYPTO (@egragcrypto) shared a long-term weekly chart showing XRP trading within a multi-year descending triangle that has been developing since the 2018 peak. The descending resistance trendline, referred to as the “Line of Hestia,” continues to limit upside attempts.

Long-Term Chart Signals Mixed Outlook for XRP

XRP tests key support inside a long-term descending triangle, capped by the “Line of Hestia” resistance. Source: @egragcrypto via X

The chart suggests XRP is once again testing triangle support, an area where historical probability models often favor upward resolution. According to technical pattern studies, descending triangles resolve to the upside approximately 70% of the time, although the projected resolution window in this case extends as far as 2027, drawing skepticism from parts of the trading community.

This longer-term structure highlights the contrast between short-term momentum signals and broader cyclical consolidation, underscoring the complexity of XRP’s current market position.

Final Thoughts

XRP currently sits at a pivotal juncture, where short-term technical signals suggest potential stabilization, yet broader market structure continues to warrant caution. Holding the $1.83–$1.90 support zone remains critical, as sustained defense could open the door to a modest recovery, while a breakdown may invite further downside pressure.

Final Thoughts

XRP was trading at around 1.87, down 1.41% in the last 24 hours at press time. Source: XRP price via Brave New Coin

As momentum indicators, volume trends, and overall market sentiment evolve, traders are advised to remain patient and disciplined. While oversold conditions may offer tactical opportunities, unresolved risks underscore the importance of prudent risk management. These insights reflect prevailing market dynamics and do not constitute investment advice.

Source link

Read More
18 12, 2025

XAU/USD Holds Near $4,330 as Softer U.S. CPI Revives Fed-Cut Bets

By |2025-12-18T22:47:38+02:00December 18, 2025|Forex News, News|0 Comments


Gold prices are consolidating near record territory on Thursday, December 18, 2025, as traders juggle two powerful forces pulling in opposite directions: a still-resilient U.S. dollar and the renewed case for lower U.S. interest rates after a cooler-than-expected inflation reading.

In early trading, spot gold was around the $4,330-per-ounce area, modestly lower on the day after a strong prior-session move, while U.S. gold futures were also fractionally softer. [1]

But the bigger story for bullion today is macro: U.S. CPI cooled to 2.7% year-on-year in November, under the 3.1% consensus forecast in a Reuters poll—fuel for the “rates can fall further” narrative that has helped propel gold’s historic 2025 rally. [2]

Gold price snapshot around today’s 09:55 update

Gold’s headline price action on Dec. 18 is best described as steady-to-soft, not a collapse—more like a market taking a breath near all-time highs after an extraordinary year.

  • Spot gold: roughly $4,330/oz (slightly down on the session) [3]
  • U.S. gold futures: roughly $4,360/oz (also slightly lower) [4]

A later read from Reuters showed spot gold down 0.4% to $4,323.57/oz (as of 12:10 GMT) with U.S. futures down 0.4% to $4,356.10, underscoring the day’s “small dip” tone rather than any trend break. [5]

Investing.com, meanwhile, cited spot gold at $4,336.54/oz at 09:15 ET (14:15 GMT), with February gold futures at $4,370.30/oz—again consistent with a narrow, high-level range. [6]

What’s driving gold today: dollar strength vs. rate-cut optimism

1) The U.S. dollar was a near-term headwind—until CPI hit

One of the simplest relationships in commodities is also one of the most reliable: a stronger dollar can pressure gold, because it makes dollar-priced bullion more expensive for overseas buyers.

Reuters noted the dollar index edged up after touching a near one-week high the prior session, a factor weighing on gold as traders positioned cautiously ahead of inflation data. [7]

But CPI shifted the balance.

After the data, Reuters reported the dollar index weakened (down 0.12% to 98.25 in that update) and Treasury yields fell, an environment that typically improves gold’s appeal. [8]

2) U.S. inflation surprised lower: CPI 2.7% vs. 3.1% expected

The headline macro catalyst today is the CPI undershoot:

  • Headline CPI:+2.7% YoY in November
  • Core CPI (ex food & energy):+2.6% YoY
  • Consensus forecast:+3.1% YoY for headline CPI (Reuters poll) [9]

There’s an important nuance: Reuters reported the CPI release was affected by a 43-day government shutdown, and the Bureau of Labor Statistics did not publish month-to-month CPI changes because October data collection was disrupted. That “data quality caveat” is a big reason why markets may be hesitant to chase gold aggressively higher on a single print. [10]

Even so, softer inflation tends to push investors toward the view that real yields can fall, which is a structural positive for non-yielding assets like gold. [11]

The Fed narrative: rate cuts, politics, and the next chair question

Gold’s 2025 surge has been tightly linked to the belief that the U.S. is in, or nearing, a lower-rate regime. Today’s flow of Fed-related headlines reinforced that debate.

Reuters highlighted that:

  • Markets were pricing two additional 25-basis-point rate cuts next year in the update it cited. [12]
  • Fed Governor Christopher Waller said the central bank still has room to cut amid rising job market weakness. [13]
  • U.S. President Donald Trump said the next Fed chair will be someone who believes in lower interest rates “by a lot,” and that a successor to Fed Chair Jerome Powell would be announced early next year. [14]

For bullion investors, this mix matters because gold can react to two things at once:

  1. Actual policy expectations (rate cuts = supportive), and
  2. Perceived institutional risk (concerns about independence or political pressure can support safe-haven demand).

Reuters’ broader gold-forecast reporting this week explicitly included worries about Fed independence among the factors analysts see supporting bullion into 2026. [15]

Central bank day in Europe adds context: BoE cuts, ECB holds, BoJ next

Dec. 18 isn’t only about the Fed. It’s also a heavyweight central-bank week globally, and those decisions feed into FX and bond-market moves that spill over into gold.

Investing.com reported:

  • The Bank of England cut rates by 25 bps
  • The European Central Bank held rates steady
  • The Bank of Japan decision is due Friday, with markets widely pricing a 25 bps hike [16]

That mix matters for gold in two ways:

  1. Currency channels: The more global central banks diverge, the more volatile FX can become—often boosting demand for hard assets as portfolio stabilizers.
  2. Global real-rate expectations: If major central banks lean easier (or if easing cycles broaden), it can reinforce the long-run case for holding gold.

Silver, platinum, palladium: the broader precious-metals complex is still “hot”

Gold isn’t moving in isolation. On Dec. 18, Reuters and Investing.com both highlighted unusual strength across precious metals:

  • Silver hovered close to its record highs after a huge year-to-date surge, supported by industrial demand and a supply deficit. [17]
  • Reuters cited silver’s record high at $66.88/oz in the prior session and noted the metal had risen ~129% year-to-date in that report. [18]
  • Platinum and palladium also pushed to multi-year highs in Reuters’ update, reflecting a broad “metals bid,” not just a gold-only trade. [19]

Why this matters for gold: when the whole complex runs together, positioning risk rises—profit-taking in one metal can spill into others, even if gold’s fundamentals remain bullish.

Regional news that matters: Thailand targets gold-trade flows, Australia posts a “gold bonanza”

Thailand: central bank calls for tighter gold-trade controls

One of today’s most striking region-specific stories comes from Thailand, where policymakers are explicitly linking gold trading to currency-market stress.

Reuters reported the Thai central bank is urging the finance ministry to regulate gold trading after a surge in transactions helped push the baht higher, with the governor saying that on days of sharp baht strength, gold transactions can account for about half of the flows driving the move. [20]

For global gold readers, the takeaway is bigger than Thailand: it’s a real-time example of how active gold trading and cross-border flows can become macro-relevant, affecting currencies, policy debates, and potentially even local market access and liquidity.

Australia: higher export earnings, gold becomes a top-tier export

Australia’s government-linked commodity outlook also underscored how gold’s high price level is reshaping the real economy.

Reuters reported Australia revised expected resource export earnings up 4% to A$383 billion for the current financial year, pointing to record gold prices as a key contributor. It also said gold is set to become Australia’s second most valuable resource export (after iron ore) in the 2025–26 financial year. [21]

Notably, that report included a forward-looking anchor: it said gold prices are likely to remain strong at around $4,000/oz over 2026 before falling in 2027 (in that outlook). [22]

That matters for the “forecast” question investors keep asking: even more cautious government-linked assumptions are now using $4,000 gold as a baseline for next year—a remarkable reset compared with the pre-2024 era.

Gold forecast 2026: why $5,000 is on the table—and why the rally could cool

A day before today’s CPI-driven headlines, Reuters published one of the most comprehensive roundups of the market’s 2026 gold forecasts—and the range is wide.

Key points from that Reuters analysis:

  • Gold is up ~64% in 2025 and hit a record $4,381/oz in October. [23]
  • Analysts at JPMorgan, Bank of America, and Metals Focus see bullion reaching $5,000/oz in 2026. [24]
  • Morgan Stanley forecast gold at $4,500/oz by mid-2026, while JPMorgan projected averages above $4,600 in Q2 and more than $5,000 in Q4, and Metals Focus saw $5,000 by end-2026. [25]
  • More conservative, Macquarie projected an average of $4,225 in 2026, describing a world that may “stabilise a bit,” with growth improving and real rates staying relatively high. [26]

The structural pillars bulls keep citing

The same Reuters report laid out why strategists believe this cycle has different “supports” than older gold booms:

  • Central-bank reserve diversification is expected (for a fifth consecutive year) to underpin demand. [27]
  • JPMorgan’s metals strategy team estimated that to keep prices flat, quarterly central bank + investment demand of about 350 metric tons is needed—and forecast buying could average 585 tons per quarter in 2026. [28]
  • Investor gold holdings as a share of total assets under management rose to 2.8% from pre-2022 levels of 1.5% (per JPMorgan’s commentary in that report), indicating a bigger strategic allocation pool than in prior cycles. [29]

The risks: corrections, forced selling, and “bubble” talk

Even in a bullish framework, the risks are real:

  • Reuters reported the BIS warned this month that gold and share prices soaring together is a phenomenon not seen in at least half a century, raising questions about potential bubbles. [30]
  • Analysts noted that sharp equity drawdowns can sometimes force liquidation of even safe-haven holdings—meaning gold can dip in a broader de-risking event. [31]
  • The same Reuters piece flagged that jewelry demand fell 23% in Q3, and that central bank purchases and ETF inflows could slow in 2026—implying the rally may persist, but with less explosive momentum. [32]

Analysis: why gold is “pausing” today, not reversing

Thursday’s price action fits a common late-cycle pattern in strong bull markets:

  1. Macro news turns favorable (cooler CPI, more rate-cut odds)
  2. Gold does not instantly surge because traders had already positioned for the theme—or because they’re waiting for confirmation amid data noise
  3. The market consolidates at a high level, letting other metals (silver/platinum) absorb more of the speculative heat

Investing.com explicitly described profit-taking after a sharp rally over the past week, while still pointing to “structural support” from central-bank buying and de-dollarisation themes. [33]

And Reuters captured the same cautious tone ahead of CPI, quoting UBS strategist Giovanni Staunovo on investors preferring not to head into the inflation report with open risk. [34]

What to watch next for the gold price

Gold’s next decisive move is likely to come from a combination of policy confirmation and liquidity:

  • December inflation data (released mid-January): Reuters noted some strategists see the November CPI as unusually noisy because of shutdown-related collection issues—making the next CPI prints critical for rate-cut conviction. [35]
  • Fed January meeting expectations: The market is already debating how soon cuts resume, and CPI has nudged that conversation. [36]
  • Bank of Japan decision Friday: If the BoJ surprises, it can drive yen moves and global bond-market repricing, with knock-on effects for gold. [37]
  • Whether the dollar trend breaks: Today’s post-CPI dip in the dollar index matters if it becomes persistent rather than a one-session reaction. [38]

Bottom line: Gold’s 2025 bull market remains intact—and the 2026 debate is now about “how high,” not “whether”

As of today’s 09:55 update on December 18, 2025, gold remains firmly parked near the $4,330/oz region, reflecting a market that is digesting softer U.S. inflation while still respecting short-term dollar strength and profit-taking near records. [39]

The most important shift in today’s news flow is not the day’s small price dip. It’s the macro narrative reset: with CPI at 2.7% YoY versus 3.1% expected, the case for further easing in 2026 looks stronger—exactly the environment where gold has historically done well. [40]

And with major banks now openly discussing $4,500 to $5,000 gold scenarios in 2026—alongside more conservative forecasts that still sit above $4,200—the metal enters year-end not as a fringe hedge, but as a core macro asset class that’s forcing governments, central banks, and investors to adapt. [41]

XAUUSD Gold Technical Analysis Levels Revealed

References

1. www.reuters.com, 2. www.reuters.com, 3. www.reuters.com, 4. www.reuters.com, 5. www.reuters.com, 6. ng.investing.com, 7. www.reuters.com, 8. www.reuters.com, 9. www.reuters.com, 10. www.reuters.com, 11. www.reuters.com, 12. www.reuters.com, 13. www.reuters.com, 14. www.reuters.com, 15. www.reuters.com, 16. ng.investing.com, 17. www.reuters.com, 18. www.reuters.com, 19. www.reuters.com, 20. www.reuters.com, 21. www.reuters.com, 22. www.reuters.com, 23. www.reuters.com, 24. www.reuters.com, 25. www.reuters.com, 26. www.reuters.com, 27. www.reuters.com, 28. www.reuters.com, 29. www.reuters.com, 30. www.reuters.com, 31. www.reuters.com, 32. www.reuters.com, 33. ng.investing.com, 34. www.reuters.com, 35. www.reuters.com, 36. www.reuters.com, 37. ng.investing.com, 38. www.reuters.com, 39. www.reuters.com, 40. www.reuters.com, 41. www.reuters.com



Source link

Read More
Go to Top